Institutional investors hold a majority ownership of BMY through the 70.80% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2016, these large investors purchased a net $67.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 6.8 Million shares of Bristol-Myers Squibb
D. E. SHAW & CO. LP Bought 6.0 Million shares of Bristol-Myers Squibb
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.9 Million shares of Bristol-Myers Squibb